{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:04:04Z","timestamp":1793217844014,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012280","name":"Rare Disease Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012280","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013085","name":"BC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000190","name":"University of Alberta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","heartrhythmjournal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.hrthm.2018.06.046","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T14:19:28Z","timestamp":1530627568000},"page":"1791-1799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review"],"prefix":"10.1016","volume":"15","author":[{"given":"Thomas M.","family":"Roston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel M.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Martijn","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary W.M.","family":"Laksman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padma","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystien V.V.","family":"Lieve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Atallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhayan","family":"Sanatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2018.06.046_bib1","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2018.06.046_bib2","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jacc.2011.01.026","article-title":"Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"57","author":"van der Werf","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2018.06.046_bib3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrcardio.2014.19","article-title":"Cardiac sympathetic denervation to prevent life-threatening arrhythmias","volume":"11","author":"Schwartz","year":"2014","journal-title":"Nature Reviews Cardiology"},{"key":"10.1016\/j.hrthm.2018.06.046_bib4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCEP.114.002217","article-title":"Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry","volume":"8","author":"Roston","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2018.06.046_bib5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/CIRCEP.113.000170","article-title":"Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate","volume":"6","author":"Miyake","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2018.06.046_bib6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.hrthm.2015.09.010","article-title":"Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications","volume":"13","author":"Olde Nordkamp","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2018.06.046_bib7","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/CIRCEP.112.970517","article-title":"Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives","volume":"5","author":"van der Werf","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2018.06.046_bib8","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.108.829267","article-title":"Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia","volume":"119","author":"Hayashi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2018.06.046_bib9","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2018.06.046_bib10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/jmg.2004.028993","article-title":"Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients","volume":"42","author":"Postma","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.hrthm.2018.06.046_bib11","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa0708006","article-title":"Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia","volume":"358","author":"Wilde","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2018.06.046_bib12","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.hrthm.2006.03.025","article-title":"Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing","volume":"3","author":"Tester","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2018.06.046_bib13","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/CIRCULATIONAHA.115.015731","article-title":"Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation","volume":"131","author":"De Ferrari","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2018.06.046_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jacep.2016.01.020","article-title":"Competitive sports participation in patients with catecholaminergic polymorphic ventricular tachycardia: a single center\u2019s early experience","volume":"2","author":"Ostby","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2018.06.046_bib15","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/europace\/eus031","article-title":"The role of stress test for predicting genetic mutations and future cardiac events in asymptomatic relatives of catecholaminergic polymorphic ventricular tachycardia probands","volume":"14","author":"Hayashi","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2018.06.046_bib16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/2193-1801-3-182","article-title":"Duplicate publication of articles used in meta-analysis in Korea","volume":"3","author":"Choi","year":"2014","journal-title":"Springerplus"},{"key":"10.1016\/j.hrthm.2018.06.046_bib17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/jamacardio.2017.1320","article-title":"Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia: a randomized clinical trial","volume":"2","author":"Kannankeril","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2018.06.046_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.hrthm.2013.10.027","article-title":"Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia","volume":"11","author":"Roses-Noguer","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2018.06.046_bib19","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.hrthm.2011.01.048","article-title":"Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia","volume":"8","author":"Sy","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2018.06.046_bib20","first-page":"2591","volume":"110","author":"Wathen","year":"2004"},{"key":"10.1016\/j.hrthm.2018.06.046_bib21","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/CIRCULATIONAHA.105.561571","article-title":"Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?","volume":"113","author":"Ellenbogen","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2018.06.046_bib22","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1161\/CIRCULATIONAHA.112.001120","article-title":"A multi-institutional study of implantable defibrillator lead performance in children and young adults: results of the Pediatric Lead Extractability and Survival Evaluation (PLEASE) Study","volume":"127","author":"Atallah","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2018.06.046_bib23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.joa.2016.01.002","article-title":"Clinical and electrocardiographic predictors of T wave oversensing in patients with subcutaneous ICD","volume":"32","author":"El-Chami","year":"2016","journal-title":"J Arrhythmia"},{"key":"10.1016\/j.hrthm.2018.06.046_bib24","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.ijcard.2014.08.020","article-title":"Delay to diagnosis amongst patients with catecholaminergic polymorphic ventricular tachycardia","volume":"176","author":"Kozlovski","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2018.06.046_bib25","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.hrthm.2015.03.033","article-title":"Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia","volume":"12","author":"Wanguemert","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2018.06.046_bib26","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/heartjnl-2016-310509","article-title":"Nationwide experience of catecholaminergic polymorphic ventricular tachycardia caused by RyR2 mutations","volume":"103","author":"Broendberg","year":"2017","journal-title":"Heart"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527118306726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527118306726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T23:05:17Z","timestamp":1571785517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527118306726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1547527118306726"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2018.06.046","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2018.06.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}